Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

Immune checkpoint inhibitors propelled the field of oncology with clinical responses in many different tumor types. Superior overall survival over chemotherapy has been reported in various metastatic cancers. Furthermore, prolonged disease-free and overall survival have been reported in the adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: van Willigen, Wouter W., Bloemendal, Martine, Gerritsen, Winald R., Schreibelt, Gerty, de Vries, I. Jolanda M., Bol, Kalijn F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174277/
https://www.ncbi.nlm.nih.gov/pubmed/30327656
http://dx.doi.org/10.3389/fimmu.2018.02265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174277/
https://www.ncbi.nlm.nih.gov/pubmed/30327656
http://dx.doi.org/10.3389/fimmu.2018.02265

Ejemplares similares